JAGX Jaguar Health, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 19, 2026
$3,66
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,3152 haftanın en düşüğü
$41,5352 haftanın en yükseği
P/E (TTM)
-0.1
Hisse Başına Kâr (TTM)
$-25.31
Gelir (TTM)
$28M
rozetleriniz
52 Haftlık Aralık
$0–$42
Analist Derecelendirmesi
STRONG BUY
Fiyat Hedefi
$263
P/E
-0.1
ROE
-623.4%
Net Kâr Marjı
-132.2%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
JAGX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.66
P/E (TTM)
-0.1
Hisse Başına Kâr (TTM)
$-25.31
Gelir (TTM)
$28M
ROE (TTM)
-623.4%
D/E Borç/Özsermaye (MRQ)
2.8
52 Haftlık Aralık
$0–$42
JAGX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 17 Eylül 2026 | 1-for-15 | Ters |
| 30 Nisan 2026 | 1-for-35 | Ters |
| 24 Mart 2025 | 1-for-25 | Ters |
| 23 Mayıs 2024 | 1-for-60 | Ters |
| 23 Ocak 2023 | 1-for-75 | Ters |
| 08 Eylül 2021 | 1-for-3 | Ters |
| 07 Haziran 2019 | 1-for-70 | Ters |
| 01 Haziran 2018 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$12M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-22.972020-12-31 → 2025-12-31
Serbest Nakit Akışı·2018-12-31 → 2021-12-31
Net kar marjı-132.2%2017-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | JAGX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -0.15Y ort. ≈-319.4 | ≈-319.4 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | JAGX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -93.1% | · | -296.0% | Zayıf | |
| FAVÖK Marjı (TTM) | -86.3% | · | 2.6% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -132.7% | · | 40.2% | Zayıf | |
| Net Kâr Marjı (TTM) | -132.2% | · | 30.9% | Zayıf | |
| ROA (TTM) | -89.2% | · | -69.8% | Zayıf | |
| ROE (TTM) | -623.4% | · | -56.6% | En üst düzey | |
| ROIC | -524.5% | · | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | JAGX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 2.8 | · | · | · | |
| Cari Oran (MRQ) | 0.7 | · | 5.9 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.1 | · | 5.3 | Düşük likidite | |
| Interest Coverage (Faiz Karşılama Oranı) | -685.2 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | JAGX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -1.5%5Y ort. ≈24.4% | ≈24.4% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -1.3%5Y ort. ≈13.1% | ≈13.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 4.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | JAGX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.3 | · | 0.2 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 0.0 | · | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 7.6 | · | 2.8 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$244.9K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-101.7%
Sonraki Rapor
Kas 12, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Mart 2026 | May 20, 2026 | $-13.60 | $-2.08 | -553.6% |
| 30 Eylül 2025 | $-219.80 | $-181.36 | -21.2% | |
| 30 Haziran 2025 | $-359.10 | $-254.54 | -41.1% | |
| 31 Mart 2025 | $-584.50 | $-642.60 | 9.0% | |
| 31 Aralık 2024 | $-11.90 | $-660.45 | 98.2% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12M | $12M | $10M | $12M | $4M | $9M | $6M | $4M | $4M | $141.5K | $258.4K | $0 | |
| Cost of Revenue | $97.0K | $2M | $2M | $2M | $2M | $3M | $4M | $3M | $880.4K | $52.0K | $123.5K | · | |
| R&D Expense | $25M | $17M | $19M | $18M | $15M | $6M | $6M | $5M | $4M | $7M | $6M | $4M | |
| SG&A Expense | $19M | $16M | $17M | $18M | $17M | $14M | $14M | $12M | $11M | $6M | $5M | $4M | |
| Operating Expenses | $57M | $43M | $44M | $46M | $45M | $36M | $35M | $35M | $39M | $14M | $13M | $8M | |
| Operating Income | $-46M | $-31M | $-34M | $-34M | $-41M | $-27M | $-29M | $-31M | $-34M | $-14M | $-12M | $-8M | |
| Interest Expense | $67.0K | $231.0K | $6M | $13M | $8M | $3M | $6M | $3M | $1M | $985.5K | $3M | $345.3K | |
| Other Non-op | $43.0K | $51.0K | $200.0K | $950.0K | $-765.0K | $190.0K | $81.0K | $315.7K | $88.5K | $-11.0K | $-27.3K | · | |
| Pretax Income | $-54M | $-39M | $-42M | $-48M | $-53M | $-34M | $-39M | $-32M | $-35M | $-15M | · | · | |
| Income Tax | $0 | $0 | $0 | · | $0 | $0 | $10.0K | · | $-13M | · | · | · | |
| Net Income | $-54M | $-38M | $-41.9K | $-48.4K | $-52.6K | $-34M | $-39M | $-32M | $-22M | $-15M | $-16M | $-9M | |
| EPS (Basic) | $-22.97 | $-130.69 | $-2678.17 | $-36.18 | $-88.22 | $-3.00 | · | · | · | · | · | · | |
| EPS (Diluted) | $-22.97 | $-130.69 | $-2678.17 | $-36.18 | $-88.22 | $-3.00 | · | · | · | · | · | · | |
| Shares (Basic) | 2,332,401 | 294,534 | 15,421 | 1,311,519 | 596,154 | 12,880,868 | · | · | · | · | · | · | |
| Shares (Diluted) | 2,332,401 | 294,534 | 15,421 | 1,311,519 | 596,154 | 12,880,868 | · | · | · | · | · | · | |
| EBITDA | $-44M | · | · | · | $-39M | $-25M | $-27M | $-30M | $-34M | · | $-12M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $968.0K | $8M | $6M | $5M | $17M | $8M | $3M | $3M | $520.7K | $951.0K | $8M | $845.2K | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $995.7K | $467.7K | $5.0K | $55.9K | · | |
| Inventory | $9M | $10M | $9M | $7M | $5M | $3M | $2M | $3M | $2M | $412.8K | $229.9K | $198.0K | |
| Prepaid Expense | $2M | $12M | $10M | $7M | $4M | $2M | $1M | $1M | $497.4K | $302.7K | $324.1K | $24.2K | |
| Current Assets | $20M | $32M | $28M | $22M | $28M | $18M | $10M | $8M | $4M | $3M | $8M | $4M | |
| PP&E (Net) | $463.0K | $464.0K | $496.0K | $557.0K | $650.0K | $677.0K | $710.0K | $760.6K | $1M | $885.9K | $829.2K | $872.5K | |
| PP&E (Gross) | $1M | $977.0K | $961.0K | $961.0K | $948.0K | $942.0K | $935.0K | $934.3K | $1M | $938.6K | $834.4K | $872.5K | |
| Accum. Depreciation | $558.0K | $513.0K | $465.0K | $404.0K | $298.0K | $265.0K | $225.0K | $173.7K | $112.8K | $52.6K | $5.2K | · | |
| Goodwill | · | · | · | · | · | · | · | $5M | $5M | $0 | · | · | |
| Intangibles | $16M | $18M | $20M | $22M | $23M | $24M | $26M | $32M | $33M | · | · | · | |
| Total Assets | $38M | $53M | $51M | $47M | $53M | $43M | $36M | $41M | $44M | $4M | $12M | $4M | |
| Accounts Payable | $9M | $5M | $5M | $6M | $5M | $5M | $5M | $5M | $7M | $517.0K | $574.5K | $698.3K | |
| Accrued Liabilities | $4M | $2M | $4M | $8M | $7M | $4M | $3M | $5M | $2M | $582.5K | $798.4K | $1M | |
| Short-term Debt | $27M | $12M | $5M | $16M | $3M | $4M | $7M | $5M | $1M | · | · | · | |
| Current Liabilities | $41M | $20M | $14M | $30M | $15M | $13M | $15M | $27M | $15M | $4M | $4M | $3M | |
| Capital Leases | $892.0K | $686.0K | $886.0K | $725.0K | $919.0K | · | · | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $6M | $6M | · | · | · | |
| Total Liabilities | $57M | $44M | $46M | $49M | $41M | $26M | $16M | $27M | $26M | $6M | $8M | $5M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $13M | $4M | $6M | · | |
| Total Debt | $27M | · | · | · | $3M | $4M | · | $5M | $3M | · | $6M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | $1.4K | $812 | $288 | |
| Retained Earnings | $-400M | $-346M | $-308M | $-267M | $-219M | $-167M | $-133M | $-95M | $-62M | $-40M | $-26M | $-9M | |
| AOCI | $-833.0K | $-467.0K | $-652.0K | $-680.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $-19M | $6M | $5M | $-1M | $12M | $17M | $11M | $5M | $17M | $-2M | $4M | $-8M | |
| Liabilities + Equity | $38M | $53M | $51M | $47M | $53M | $43M | $36M | $41M | $44M | $4M | $12M | $4M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | 14,007,132 | 8,124,923 | 2,874,330 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $584.3K | $47.5K | $5.2K | · | |
| Stock-based Comp | $831.0K | $2M | $2M | $3M | $4M | $3M | $3M | $2M | $814.6K | $717.9K | $992.2K | $164.2K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-13M | $6M | $5M | $3M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $702.8K | · | · | · | |
| Other Non-cash | $27M | · | · | · | $12M | $14M | $13M | $6M | $24M | · | $-4M | · | |
| Operating Cash Flow | $-24M | $-29M | $-33M | $-33M | $-35M | $-15M | $-20M | $-23M | $-10M | $-14M | $-14M | $-5M | |
| CapEx | · | $16.0K | · | $77.0K | $6.0K | $7.0K | · | $6.5K | · | $104.2K | $23.3K | $55.1K | |
| Investing Cash Flow | $-41.0K | $-231.0K | · | $-2M | $-6.0K | $-7.0K | · | $-6.5K | $-2M | $2M | · | · | |
| Debt Issued | · | · | · | · | · | $12M | · | · | · | · | $6M | · | |
| Net Debt Issued | · | · | · | · | $-100.0K | $12M | · | $-2M | $-2M | · | $5M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $5M | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $30 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | $-30 | $5M | · | · | · | |
| Financing Cash Flow | $24M | $31M | $34M | $23M | $44M | $19M | $22M | $25M | $11M | $5M | · | · | |
| Net Change in Cash | $-170.0K | $2M | $1M | $-12M | $9M | $4M | $1M | $2M | $-702.4K | $-7M | · | · | |
| Taxes Paid | · | · | · | · | · | · | · | $19.3K | $234.6K | $478.7K | · | · | |
| Free Cash Flow | · | · | · | · | $-35M | $-15M | · | $-23M | · | · | $-14M | · | |
| Levered FCF | · | · | · | · | $-43M | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -398.8% | · | · | · | · | -283.9% | -501.2% | -698.0% | -785.3% | · | -4816.7% | · | |
| Net Margin | -465.4% | · | · | · | · | -360.2% | -667.3% | -727.9% | -503.7% | · | -6305.2% | · | |
| Pretax Margin | -469.1% | · | · | · | · | -360.2% | -667.1% | -727.9% | -806.0% | · | · | · | |
| EBITDA Margin | -382.2% | · | · | · | · | -265.5% | -471.2% | -668.1% | -771.9% | · | -4814.7% | · | |
| ROA | -116.8% | · | · | · | -109.5% | -85.3% | -99.5% | -75.9% | -93.1% | · | -193.7% | · | |
| ROE | 907.4% | · | · | · | -314.9% | -270.4% | -349.5% | -409.3% | -296.7% | · | 849.4% | · | |
| ROIC | -524.5% | · | · | · | -270.7% | · | -271.3% | · | -107.0% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | · | · | · | 1.8 | 1.3 | 0.6 | 0.3 | 0.2 | · | 2.2 | · | |
| Quick Ratio | 0.1 | · | · | · | 0.1 | 0.8 | 0.3 | 0.1 | 0.1 | · | 2.0 | · | |
| Debt / Equity | -1.5 | · | · | · | 0.3 | 0.2 | · | 0.9 | 0.2 | · | 1.3 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.9 | · | |
| Interest Coverage | -685.2 | · | · | · | -4.8 | -9.5 | -5.1 | -11.7 | -28.3 | · | -3.8 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | · | · | · | 0.2 | 0.1 | 0.1 | 0.2 | · | 0.0 | · | |
| Inventory Turnover | 0.0 | · | · | · | 0.6 | 1.3 | 1.4 | 1.0 | 0.7 | · | 0.6 | · | |
| Receivables Turnover | 7.6 | · | · | · | · | 5.0 | 4.3 | 6.0 | 18.5 | · | 9.2 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | · | $0.54 | · | |
| Revenue / Share | $4.94 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-10.16 | · | · | · | $-0.78 | · | · | · | · | · | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | · | $0.95 | · | |
| EPS (TTM) | $-22.97 | $-130.69 | $-2678.17 | $-36.18 | $-88.22 | $-3.00 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | 19.8% | -18.4% | 175.8% | -53.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.3% | 39.2% | 1.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 4.2% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $12M | $10M | $12M | $4M | $9M | $6M | $4M | $4M | $141.5K | $258.4K | · | |
| Net Income TTM | $-54M | $-38M | $-41.9K | $-48.4K | $-52.6K | $-34M | $-39M | $-32M | $-22M | $-15M | $-16M | · | |
| P/E | -0.0 | -0.2 | -0.1 | -270.5 | -1326.2 | -91687.5 | · | · | · | · | · | · | |
| Earnings Yield | -2467.2% | -517.6% | -1182.4% | -0.37% | -0.08% | 0.00% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $20M | $3M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | · | · | · | · | · | |
| Cost of Revenue | · | $1M | $0 | $0 | $97.0K | $515.0K | · | $541.0K | $427.0K | $430.0K | $514.0K | $491.0K | $345.0K | $613.0K | $456.0K | $455.0K | |
| R&D Expense | $3M | $4M | $14M | $4M | $3M | $4M | $5M | $4M | $4M | $4M | $6M | $4M | $5M | $6M | $2M | $5M | |
| SG&A Expense | $4M | $4M | $5M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $6M | |
| Operating Expenses | $9M | $10M | $24M | $10M | $11M | $12M | $12M | $10M | $10M | $11M | $12M | $11M | $12M | $13M | $9M | $14M | |
| Operating Income | $-8M | $10M | $-21M | $-7M | $-8M | $-9M | $-8M | $-7M | $-7M | $-8M | $-9M | $-8M | $-10M | $-10M | $-6M | $-12M | |
| Interest Expense | $161.0K | $699.0K | $132.0K | $6.0K | $-15.0K | $-56.0K | $-110.0K | $-162.0K | $-108.0K | $611.0K | $500.0K | $3M | $2M | $3M | $3M | $4M | |
| Other Non-op | $378.0K | $205.0K | $-297.0K | $-94.0K | $322.0K | $112.0K | $378.0K | $168.0K | $-729.0K | $234.0K | $-70.0K | $26.0K | $-12.0K | $-158.0K | $-1M | $832.0K | |
| Pretax Income | $-13M | $9M | $-23M | $-10M | $-11M | $-11M | $-10M | $-10M | $-10M | $-9M | $-8M | $-12M | $-12M | $-13M | $-9M | $-18M | |
| Income Tax | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| Net Income | $-13M | $9M | $-23M | $-10M | $-11M | $-11M | $-10M | $-10M | $-9M | $-9M | $-8M | $-12M | $-12M | $-13M | $-9M | $-18M | |
| EPS (Basic) | $-15.70 | $-13.60 | $10.27 | $-6.28 | $-358.94 | $-584.45 | $-14.62 | $-26.29 | $-2.66 | $-87.12 | $-22.50 | $-41.35 | $-2.39 | $-8.83 | $-8.77 | $-23.10 | |
| EPS (Diluted) | $-15.70 | $-13.60 | $10.27 | $-6.28 | $-358.94 | $-584.45 | $-14.62 | $-26.29 | $-2.66 | $-87.12 | $-22.50 | $-41.35 | $-2.39 | $-8.83 | $-8.77 | $-23.10 | |
| Shares (Basic) | 809,122 | 515,788 | · | 1,513,178 | 28,994 | 17,904 | · | 374,805 | 3,572,984 | 105,895 | 345,657 | 293,858 | 5,109,609 | 1,418,159 | 1,068,267 | 778,512 | |
| Shares (Diluted) | 809,122 | 515,788 | · | 1,513,178 | 28,994 | 17,904 | · | 374,805 | 3,572,984 | 105,895 | 345,657 | 293,858 | 5,109,609 | 1,418,159 | 1,068,267 | 778,512 | |
| EBITDA | $-8M | $11M | · | $-7M | $-8M | $-9M | · | $-7M | $-7M | $-8M | $-9M | $-8M | $-9M | $-10M | $-6M | $-11M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $968.0K | $4M | $2M | $6M | $8M | $13M | $16M | $12M | $3M | $9M | $14M | $11M | $9M | $17M | |
| Receivables | $8.0K | $68.0K | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $1M | $987.0K | $2M | $2M | $2M | |
| Inventory | $7M | $8M | $9M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $8M | $8M | $9M | $7M | $7M | $5M | |
| Prepaid Expense | $3M | $2M | $2M | $14M | $14M | $13M | $12M | $12M | $13M | $11M | $9M | $10M | $8M | $6M | $6M | $4M | |
| Current Assets | $18M | $20M | $20M | $29M | $28M | $30M | $32M | $37M | $40M | $34M | $22M | $28M | $32M | $25M | $23M | $28M | |
| PP&E (Net) | $417.0K | $423.0K | $463.0K | $483.0K | $441.0K | $452.0K | $464.0K | $476.0K | $488.0K | $484.0K | $511.0K | $526.0K | $541.0K | $572.0K | $583.0K | $600.0K | |
| PP&E (Gross) | $987.0K | $987.0K | $1M | $1M | $977.0K | $977.0K | $977.0K | $977.0K | $977.0K | $961.0K | $961.0K | $961.0K | $961.0K | $1M | $1M | $1M | |
| Accum. Depreciation | $570.0K | $564.0K | $558.0K | $550.0K | $536.0K | $525.0K | $513.0K | $501.0K | $489.0K | $477.0K | $450.0K | $435.0K | $420.0K | $454.0K | $439.0K | $423.0K | |
| Intangibles | $15M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | $19M | $20M | $21M | $21M | $22M | $23M | $23M | $22M | |
| Total Assets | $34M | $37M | $38M | $49M | $48M | $51M | $53M | $58M | $61M | $55M | $45M | $52M | $57M | $51M | $50M | $53M | |
| Accounts Payable | $5M | $5M | $9M | $8M | $7M | $7M | $5M | $5M | $4M | $3M | $5M | $5M | $6M | $6M | $6M | $4M | |
| Accrued Liabilities | $5M | $4M | $4M | $4M | $4M | $2M | $2M | $3M | $3M | $3M | $3M | $10M | $9M | $9M | $9M | $8M | |
| Short-term Debt | $14M | $22M | $27M | $23M | $19M | $19M | $12M | $11M | $11M | $10M | $4M | $14M | $16M | $12M | $8M | $7M | |
| Current Liabilities | $25M | $41M | $41M | $36M | $29M | $28M | $20M | $20M | $19M | $18M | $12M | $29M | $31M | $27M | $23M | $19M | |
| Capital Leases | $873.0K | $898.0K | $892.0K | $918.0K | $960.0K | $998.0K | $686.0K | $754.0K | $812.0K | $873.0K | $351.0K | $495.0K | $627.0K | $738.0K | $868.0K | $921.0K | |
| Total Liabilities | $29M | $53M | $57M | $45M | $41M | $48M | $44M | $43M | $42M | $41M | $44M | $46M | $49M | $48M | $47M | $45M | |
| Total Debt | $14M | $22M | · | $23M | $19M | $19M | · | $11M | $11M | $10M | $4M | $14M | $16M | $12M | $8M | $7M | |
| Retained Earnings | $-404M | $-391M | $-400M | $-377M | $-367M | $-357M | $-346M | $-337M | $-327M | $-317M | $-299M | $-291M | $-279M | $-259M | $-247M | $-237M | |
| AOCI | $-1M | $-1M | $-833.0K | $-839.0K | $-719.0K | $-700.0K | $-467.0K | $-687.0K | $-542.0K | $-461.0K | $-796.0K | $-723.0K | $-884.0K | · | · | · | |
| Stockholders' Equity | $5M | $-16M | $-19M | $4M | $7M | $830.0K | $6M | $13M | $17M | $12M | $1M | $6M | $8M | $4M | $3M | $8M | |
| Liabilities + Equity | $34M | $37M | $38M | $49M | $48M | $51M | $53M | $58M | $61M | $55M | $45M | $52M | $57M | $51M | $50M | $53M |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $473.0K | $473.0K | $477.0K | $479.0K | $478.0K | $479.0K | $478.0K | $474.0K | $447.0K | $501.0K | $504.0K | $503.0K | $504.0K | $498.0K | $558.0K | $426.0K | |
| Stock-based Comp | $171.0K | $155.0K | $116.0K | $135.0K | $279.0K | $301.0K | $372.0K | $305.0K | $383.0K | $581.0K | $528.0K | $527.0K | $480.0K | $741.0K | $1M | $1M | |
| Amort. of Intangibles | $467.0K | $467.0K | $498.0K | $468.0K | $467.0K | $467.0K | $516.0K | $461.0K | $434.0K | $489.0K | $489.0K | $488.0K | $488.0K | $483.0K | $422.0K | $418.0K | |
| Other Non-cash | · | $-521.0K | · | · | · | $2M | · | · | · | $1M | · | · | $1M | · | · | $9M | |
| Operating Cash Flow | $-5M | $9M | $-5M | $-5M | $-6M | $-7M | $-8M | $-6M | $-8M | $-7M | $-7M | $-9M | $-10M | $-9M | $-10M | $-8M | |
| CapEx | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $3.0K | · | · | |
| Investing Cash Flow | · | · | $13.0K | · | · | · | $-215.0K | $0 | · | · | $0 | $0 | $0 | $-56.0K | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-447.0K | |
| Financing Cash Flow | $2M | $-7M | $10M | $6M | $3M | $5M | $3M | $4M | $13M | $12M | $1M | $3M | $19M | $10M | $3M | $8M | |
| Net Change in Cash | $-3M | $2M | $4M | $1M | $-3M | $-2M | $-5M | $-3M | $4M | $5M | $-5M | $-6M | $9M | $2M | $-8M | $405.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | $-10M | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -620.2% | 50.2% | · | -234.8% | -268.8% | -425.5% | · | -233.7% | · | · | · | · | · | · | · | · | |
| Net Margin | -1045.1% | 43.0% | · | -308.2% | -349.4% | -472.6% | · | -317.1% | · | · | · | · | · | · | · | · | |
| Pretax Margin | -1045.1% | 43.0% | · | -312.9% | -354.5% | -478.6% | · | -322.4% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -620.2% | 52.6% | · | -234.8% | -268.8% | -403.9% | · | -233.7% | · | · | · | · | · | · | · | · | |
| ROA | -31.1% | 19.6% | · | -17.6% | -19.0% | -19.6% | · | -19.0% | -16.7% | -16.4% | -16.1% | -23.8% | -22.2% | -22.8% | -15.7% | -29.9% | |
| ROE | -217.0% | -116.9% | · | -108.9% | -88.7% | -165.5% | · | -135.8% | -84.7% | -94.7% | -310.2% | -283.0% | -154.8% | -100.3% | -54.4% | -90.8% | |
| ROIC | -40.5% | 161.0% | · | · | · | · | · | · | -26.0% | -37.0% | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | · | 0.8 | 1.0 | 1.1 | · | 1.8 | 2.1 | 1.9 | 1.8 | 1.0 | 1.0 | 0.9 | 1.0 | 1.5 | |
| Quick Ratio | 0.1 | 0.2 | · | 0.1 | 0.1 | 0.2 | · | 0.7 | 0.9 | 0.7 | 0.4 | 0.3 | 0.5 | 0.5 | 0.5 | 1.0 | |
| Debt / Equity | 2.8 | -1.4 | · | 5.3 | 2.7 | 22.5 | · | 0.9 | 0.7 | 0.9 | 2.5 | 2.4 | 2.0 | 3.3 | 2.9 | 0.8 | |
| Interest Coverage | -47.2 | 14.6 | · | -1206.3 | 533.8 | 168.2 | · | 44.8 | 66.6 | -13.4 | -17.6 | -2.3 | -4.5 | -3.6 | -2.6 | -2.8 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.5 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | · | · | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.0 | 0.1 | · | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | 2.1 | 31.4 | · | 2.3 | 2.4 | 1.6 | · | 2.1 | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $1.51 | $39.30 | · | $2.04 | $2.94 | $3.53 | · | $0.33 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $17.12 | · | · | · | $-11.67 | · | · | · | $-0.04 | · | · | $-1.95 | · | · | $-0.17 | |
| EPS (TTM) | $-25.31 | $-368.55 | · | $-964.29 | $-984.30 | $-628.02 | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $28M | $30M | · | $12M | $12M | $12M | · | · | · | · | · | $8M | $8M | $8M | $8M | $8M | |
| Net Income TTM | $-37M | $-35M | · | $-41M | $-41M | $-40M | · | $4M | $6M | $3M | $8M | $3M | $6M | $-2M | $-1M | $-6M | |
| P/E | -0.1 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -843.7% | -99339.6% | · | -41385.8% | -39059.5% | -13193.7% | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $12M | $12M | $10M | $12M | $4M |
| Faaliyet Kâr Marjı % | -398.8% | · | · | · | · |
| Net Gelir | $-54M | $-38M | $-41.9K | $-48.4K | $-52.6K |
| Seyreltilmiş Hisse Başı Kâr | $-22.97 | $-130.69 | $-2678.17 | $-36.18 | $-88.22 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -1.5 | · | · | · | 0.3 |
| Cari Oran | 0.5 | · | · | · | 1.8 |
| Cari Oran | 0.1 | · | · | · | 0.1 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | · | $-35M |
Kurumsal Sahipler (13F)
Kurumsal faaliyet — Q1 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 3 (0 önceki Ç'ye göre) | 2 (+1 önceki Ç'ye göre) | 3 (0 önceki Ç'ye göre) | 1 (+1 önceki Ç'ye göre) | +209K |
Q4 2025 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Sagard Capital Partners, L.P., Sagard Capital Partners GP, Inc., Sagard Capital Partners Management Corp. ×8 başvurular | 23 Aralık 2019 | · | İlk başvuru | · | SEC |
| Nantucket Investments Limited, Burford Capital Limited | 12 Şubat 2018 | · | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 21 içeriden öğrenenler · 9 yöneticiler · 12 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Carol R. Lizak | Chief Financial Officer | 11 Aralık 2025 A | 11.911 | 0 | 0 | $0 |
| Karen Steil Wright | CFO and Treasurer | 24 Temmuz 2019 A | · | 0 | 0 | $0 |
| Lisa A Conte | Chief Exec. Officer & President | 11 Aralık 2025 A | 29.258 | 0 | 0 | $0 |
| Pravin R Chaturvedi | Chief Scientific Officer | 11 Aralık 2025 A | 11.938 | 0 | 0 | $0 |
| Jonathan S. Wolin | Chief of Staff, Chief Compliance Officer & General Counsel | 11 Aralık 2025 A | 11.938 | 0 | 0 | $0 |
| Steven R. King | Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary | 11 Aralık 2025 A | 11.885 | 0 | 0 | $0 |
| Roger J. Waltzman | Chief Scientific Officer | 19 Aralık 2016 A | · | 0 | 0 | $0 |
| Philippe Brianceau | Chief Veterinary Officer | 01 Nisan 2016 A | · | 0 | 0 | $0 |
| Michael Hauser | Chf Veterinarian, Clinical Ops | 18 Mayıs 2015 A | · | 0 | 0 | $0 |
| Anula Jayasuriya | Yönetim kurulu üyesi | 11 Aralık 2025 A | 5.916 | 0 | 0 | $0 |
| Jonathan B. Siegel | Yönetim kurulu üyesi | 11 Aralık 2025 A | 7.423 | 0 | 0 | $0 |
| James J Bochnowski | Yönetim kurulu üyesi | 11 Aralık 2025 A | 6.415 | 0 | 0 | $0 |
| John Micek | Yönetim kurulu üyesi | 11 Aralık 2025 A | 7.430 | 0 | 0 | $0 |
| Gregory J Divis | Yönetim kurulu üyesi | 18 Mayıs 2022 M | 12.133 | 0 | 0 | $0 |
| Murray David Macnaughtan | Yönetim kurulu üyesi | 24 Temmuz 2019 A | · | 0 | 0 | $0 |
| Jeffery C. Johnson | Yönetim kurulu üyesi | 24 Temmuz 2019 A | · | 0 | 0 | $0 |
| Ari Azhir | Yönetim kurulu üyesi | 12 Mart 2018 A | · | 0 | 0 | $0 |
| Folkert W. Kamphuis | Yönetim kurulu üyesi | 12 Mart 2018 A | · | 0 | 0 | $0 |
| Zhi Yang | Yönetim kurulu üyesi | 12 Mart 2018 A | 1.522.881 | 0 | 0 | $0 |
| Jiahao Qiu | Yönetim kurulu üyesi | 12 Mart 2018 A | · | 0 | 0 | $0 |
| Jonathan M Glaser | · | 25 Eylül 2018 G | 720.405 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
JAGX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$262.50
+7072,1%
3 42,9%
Güçlü Al
3 42,9%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-07-17Ortalama hedef $262.50 +7072,1%
Düşük$262.50
Ortalama$262.50
Yüksek$262.50
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| JAGX | · | -0.0 | -1.5% | -465.4% | 907.4% | · |
| TRAW | · | 1.4 | 1134.5% | · | · | · |
| CURX | $9M | -1.9 | · | · | -73.3% | · |
| CNSP | · | -0.1 | · | · | · | · |
| ENVB | $4M | -0.1 | -94.1% | 8275459.4% | -275.8% | · |
| RVPH | $2M | · | · | · | -485.2% | · |
| QCLS | · | -0.5 | · | · | · | · |
| SNOA | $4M | -1.1 | 36.7% | -16.3% | -92.3% | 38.0% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 19, 2026